Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Total 13F shares
-
4,549,767
-
Share change
-
+1,877,011
-
Total reported value
-
$7,142,810
-
Price per share
-
$1.57
-
Number of holders
-
15
-
Value change
-
+$3,023,403
-
Number of buys
-
10
-
Number of sells
-
7
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q3 2024
As of 30 Sep 2024,
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,549,767 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, SPHERA FUNDS MANAGEMENT LTD., Yelin Lapidot Holdings Management Ltd., MORGAN STANLEY, Ikarian Capital, LLC, TWO SIGMA SECURITIES, LLC, KESTRA PRIVATE WEALTH SERVICES, LLC, RHUMBLINE ADVISERS, BOOTHBAY FUND MANAGEMENT, LLC, and XTX Topco Ltd.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.